Renovaro Biosciences Denmark ApS: Financial statements 2018
CVR: 26027322
Source: annual report 2018, Danish Business Authority
01/07/2017 – 30/06/2018
Renovaro Biosciences Denmark ApS (CVR 26027322) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK -4,470,967 and a net result of DKK -7,012,131. Equity in the 2018 report amounted to DKK -55,793,173.
- Gross Profit
- DKK -4,470,967
- Profit/Loss
- DKK -7,012,131
- Equity
- DKK -55,793,173
- Total Assets
- DKK 3,073,582
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | -4.5M | -7M | -55.8M | - |
| 2016 | - | -5M | -10.7M | -52M | 2 |
| 2015 | - | -17.4M | -20.4M | -41.3M | - |
| 2014 | - | -8.5M | -11.5M | -21M | - |
| 2013 | - | -5.6M | -10.6M | -9.5M | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
As of November 15, 2018, Henrik Grønfeldt-Sørensen is registered as adm. dir. of Renovaro Biosciences Denmark ApS.
As of November 15, 2018, Eric Jean Marie Leire has stepped down as adm. dir. of Renovaro Biosciences Denmark ApS.
On November 15, 2018, the company changed its name from DanDrit Biotech ApS to Enochian BioSciences Denmark ApS.
As of April 1, 2018, Henrik Grønfeldt-Sørensen has left the board of directors of Renovaro Biosciences Denmark ApS.
As of April 1, 2018, Torben Bjørn Christensen has left the board of directors of Renovaro Biosciences Denmark ApS.
As of April 1, 2018, Eric Jean Marie Leire has left the board of directors of Renovaro Biosciences Denmark ApS.
On April 1, 2018, the company changed its name from DANDRIT BIOTECH A/S to DanDrit Biotech ApS.
About Renovaro Biosciences Denmark ApS
Renovaro Biosciences Denmark ApS is a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2001. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Enochian BioSciences Denmark ApS and DanDrit Biotech ApS. The management consists of David Hershel Weinstein. The company is owned by Lunai Bioworks Inc.. The company has 1 employee (2017). In 2026, the company reported a gross profit of DKK -4,478 and a net result of DKK -1,178,038 compared with DKK -4,629,959 the year before. Equity in the 2026 report amounted to DKK -91,933,986.
